Atomo Diagnostics Valuation Multiples
Discover revenue and EBITDA valuation multiples for Atomo Diagnostics.
Atomo Diagnostics Overview
About Atomo Diagnostics
Atomo Diagnostics Ltd is an Australian medical device design innovator and original equipment manufacturing company. The company is engaged in the development and sale of medical devices. The company develops point-of-care devices for rapid diagnostic testing. The company offers AtomoRapid RDT Platform with devices including Galileo, Pascal, Curie, and Elion. The firm operates in a single segment, medical device research and development.
Founded
2010
HQ
Employees
N/A
Website
Financials (FY)
EV
$9M
Valuation Multiples
Start free trial
Atomo Diagnostics Financials
Atomo Diagnostics reported last fiscal year revenue of $2M.
In the same fiscal year, Atomo Diagnostics generated $983K in gross profit and had net loss of ($4M).
Atomo Diagnostics P&L
In the most recent fiscal year, Atomo Diagnostics reported revenue of $2M and net income of ($4M).
Atomo Diagnostics is unprofitable as of last fiscal year, with gross margin of 42% and net margin of (153%).
Financial data powered by Morningstar, Inc.
Atomo Diagnostics Stock Performance
Atomo Diagnostics has current market cap of $12M, and enterprise value of $9M.
Atomo Diagnostics' stock price is $0.01.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $9M | $12M | -0.2% | - | - | - | $-0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAtomo Diagnostics Valuation Multiples
Atomo Diagnostics trades at 4.1x EV/Revenue multiple.
Atomo Diagnostics Financial Valuation Multiples
As of September 3, 2026, Atomo Diagnostics has market cap of $12M and EV of $9M.
Atomo Diagnostics has a P/E ratio of (3.3x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Atomo Diagnostics Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Atomo Diagnostics Margins & Growth Rates
In the most recent fiscal year, Atomo Diagnostics reported gross margin of 42% and net margin of (153%).
Atomo Diagnostics Margins
Data powered by FactSet, Inc. and Morningstar, Inc.
Atomo Diagnostics Operational KPIs
Data powered by FactSet, Inc. and Morningstar, Inc.
Atomo Diagnostics Competitors
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
This data is available for Pro users. Sign up to see all Atomo Diagnostics competitors and their valuation data. Start Free Trial | ||||||
Atomo Diagnostics VC Funding History
Before going public, Atomo Diagnostics raised $4M in total equity funding, across 3 rounds.
Atomo Diagnostics Funding Rounds
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Atomo Diagnostics
| When was Atomo Diagnostics founded? | Atomo Diagnostics was founded in 2010. |
| Where is Atomo Diagnostics headquartered? | Atomo Diagnostics is headquartered in Australia. |
| Is Atomo Diagnostics publicly listed? | Yes, Atomo Diagnostics is a public company listed on Australian Securities Exchange. |
| What is the stock symbol of Atomo Diagnostics? | Atomo Diagnostics trades under AT1 ticker. |
| When did Atomo Diagnostics go public? | Atomo Diagnostics went public in 2020. |
| Who are competitors of Atomo Diagnostics? | Atomo Diagnostics main competitors include |
| What is the current market cap of Atomo Diagnostics? | Atomo Diagnostics' current market cap is $12M. |
| What is the current revenue of Atomo Diagnostics? | Atomo Diagnostics' last fiscal year revenue is $2M. |
| What is the current EV/Revenue multiple of Atomo Diagnostics? | Current revenue multiple of Atomo Diagnostics is 4.1x. |
| Is Atomo Diagnostics profitable? | No, Atomo Diagnostics is not profitable. |
| How many companies Atomo Diagnostics has acquired to date? | Atomo Diagnostics hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Atomo Diagnostics has invested to date? | Atomo Diagnostics hasn't invested in any companies yet (or none have been disclosed publicly). |
Lists including Atomo Diagnostics
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.